Australia markets open in 4 hours 52 minutes

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
114.99-0.09 (-0.08%)
As of 3:08PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5203.21B
Enterprise value 3276.95B
Trailing P/E 31.01
Forward P/E 18.23
PEG ratio (5-yr expected) 12.04
Price/sales (ttm)3.78
Price/book (mrq)16.17
Enterprise value/revenue 35.16
Enterprise value/EBITDA 710.01

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 324.32%
S&P500 52-week change 331.46%
52-week high 3119.15
52-week low 379.11
50-day moving average 3115.87
200-day moving average 3111.14

Share statistics

Avg vol (3-month) 36.24M
Avg vol (10-day) 35.82M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 1.74B
% held by insiders 10.13%
% held by institutions 169.05%
Shares short (14 July 2021) 414.66M
Short ratio (14 July 2021) 42.49
Short % of float (14 July 2021) 40.83%
Short % of shares outstanding (14 July 2021) 40.83%
Shares short (prior month 14 June 2021) 413.34M

Dividends & splits

Forward annual dividend rate 45.2
Forward annual dividend yield 44.47%
Trailing annual dividend rate 35.08
Trailing annual dividend yield 34.41%
5-year average dividend yield 44.22
Payout ratio 4134.05%
Dividend date 315 Aug 2021
Ex-dividend date 413 July 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021


Profit margin 12.40%
Operating margin (ttm)35.17%

Management effectiveness

Return on assets (ttm)7.94%
Return on equity (ttm)48.86%

Income statement

Revenue (ttm)53.73B
Revenue per share (ttm)30.36
Quarterly revenue growth (yoy)33.90%
Gross profit (ttm)31.75B
Net income avi to common (ttm)6.6B
Diluted EPS (ttm)3.71
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.6B
Total cash per share (mrq)4.87
Total debt (mrq)82.16B
Total debt/equity (mrq)652.34
Current ratio (mrq)0.91
Book value per share (mrq)7.11

Cash flow statement

Operating cash flow (ttm)20.45B
Levered free cash flow (ttm)18.18B